Zara Baloch, Director Quantitative Research and Meta Analysis at MedNews Week, shared Alicia Fong’s, Research Assistant, Mount Sinai Health Systemon, post on LinkedIn, adding:
”The treatment landscape for muscle-invasive bladder cancer (MIBC) is evolving rapidly, with new data raising important questions about how we approach perioperative therapy and treatment selection.
In this MedNews Week Medical Spotlight, Dr. Karine Tawagi shares her perspective on the changing MIBC paradigm from perioperative chemo-immunotherapy and the implications of the NIAGARA trial, to the emerging role of ctDNA and the practical challenge of translating advances into accessible, equitable care.
A timely and insightful discussion on where GU oncology is heading.
Quoting Alicia Fong’s post:
”Medicine is evolving– and so are the paths we take to shape its future.
In this Medical Spotlight, Dr. Karine Tawagi shares her perspective on the rapidly evolving treatment paradigms in muscle-invasive bladder cancer (MIBC), including emerging approaches and the future of MIBC care.
Along the way, Dr. Tawagi reflects on the mentors who shaped her journey into oncology and inspired her approach as an educator today.
You can also read: Central Nervous System (CNS) Lymphoma: Reaching the Tumor Across CNS Barriers
